January 14, 2014
The Health Minister Norihisa Tamura warned on January 10 that the clinical study scandal over Novartis Pharma’s hypertension drug Diovan (valsartan) could shake confidence in Japanese clinical studies. The Ministry of Health, Labor and Welfare filed a criminal complaint a...read more